Altimmune Stock (NASDAQ: ALT) stock price, news, charts, stock research, profile.
Open | $7.10 |
Close | $6.74 |
Volume / Avg. | 3.47M / 3.59M |
Day Range | 6.71 - 7.47 |
52 Wk Range | 2.09 - 14.84 |
Market Cap | $484.26M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 32.9% |
Days to Cover | 9.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Altimmune (NASDAQ:ALT) through any online brokerage.
Other companies in Altimmune’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Pharming (NASDAQ:PHAR).
There is no analysis for Altimmune.
Altimmune has a consensus price target of $19.25.
The stock price for Altimmune (NASDAQ: ALT) is $6.83 last updated July 2, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Altimmune.
Altimmune’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Altimmune.
Altimmune is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.